{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-008918","form_type":"8-K","ticker":"IMCR","cik":"0001671927","company_name":"Immunocore Holdings plc","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.388540+00:00","generated_at":"2026-05-24T15:50:08.679953+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Immunocore registers up to $150M of 2.50% convertible notes for resale by selling holders","bullets":["Filed prospectus supplement on March 17, 2025 covering resale of up to $150M aggregate principal of 2.50% Convertible Senior Notes due 2030.","Entered first supplemental indenture to add Trust Indenture Act provisions; legal opinions from Cooley (UK) LLP and Cooley LLP attached.","Selling securityholders may also resell ADSs and ordinary shares issuable upon conversion of the notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-008918","json":"https://secwatch.observer/filing/0001140361-25-008918.json","markdown":"https://secwatch.observer/filing/0001140361-25-008918.md","text":"https://secwatch.observer/filing/0001140361-25-008918.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671927/000114036125008918/0001140361-25-008918-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671927/000114036125008918/ny20045585x2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T15:50:08.679953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}